HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jingwei Chi Selected Research

Erythrokeratodermia Variabilis

11/2015Pathogenic Cx31 is un/misfolded to cause skin abnormality via a Fos/JunB-mediated mechanism.
1/2012Pathogenic connexin-31 forms constitutively active hemichannels to promote necrotic cell death.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jingwei Chi Research Topics

Disease

8Neoplasms (Cancer)
10/2020 - 01/2016
3Diabetic Nephropathies (Diabetic Nephropathy)
11/2020 - 01/2020
3Papillary Thyroid Cancer
01/2020 - 01/2017
2Inflammation (Inflammations)
04/2021 - 10/2020
2Hyperglycemia
10/2020 - 05/2019
2Erythrokeratodermia Variabilis
11/2015 - 01/2012
1Type 2 Diabetes Mellitus (MODY)
05/2022
1Glucose Intolerance
05/2022
1Diabetes Mellitus
05/2022
1Wounds and Injuries (Trauma)
01/2022
1Gout
01/2022
1Non-alcoholic Fatty Liver Disease
01/2022
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2022
1Gouty Arthritis
04/2021
1Diabetic Angiopathies (Diabetic Angiopathy)
11/2020
1Kidney Diseases (Kidney Disease)
10/2020
1COVID-19
10/2020
1Cardiovascular Diseases (Cardiovascular Disease)
10/2020
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
10/2020
1Hypertension (High Blood Pressure)
10/2020
1Liver Diseases (Liver Disease)
10/2020
1Obesity
10/2020
1Diabetes Complications
01/2020
1Thyroiditis
01/2020
1Mitochondrial Diseases (Mitochondrial Disease)
01/2020
1Hyperlipoproteinemia Type IV (Type IV, Hyperlipoproteinemia)
01/2020
1Diabetic Neuropathies (Diabetic Neuropathy)
05/2019
1Insulin Resistance
01/2019
1Osteosarcoma (Osteogenic Sarcoma)
11/2018
1Neoplasm Metastasis (Metastasis)
01/2018
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2018
1Colorectal Neoplasms (Colorectal Cancer)
01/2018
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2018
1Hypertriglyceridemia
07/2017
1Pancreatitis
07/2017
1Lymphatic Metastasis
01/2017
1Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
01/2017
1Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
01/2017
1Skin Diseases (Skin Disease)
11/2015
1Breast Neoplasms (Breast Cancer)
12/2013
1Parkinson Disease (Parkinson's Disease)
08/2011
1Kufor-Rakeb syndrome
08/2011

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
01/2018 - 08/2011
3ResveratrolIBA
01/2022 - 05/2019
2MicroRNAs (MicroRNA)IBA
01/2022 - 04/2021
2Uric Acid (Urate)IBA
01/2022 - 04/2021
2Lipoprotein Lipase (Diacylglycerol Lipase)IBA
01/2020 - 07/2017
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 01/2018
2Messenger RNA (mRNA)IBA
01/2017 - 12/2013
2human GJB3 proteinIBA
11/2015 - 01/2012
1Glucose (Dextrose)FDA LinkGeneric
05/2022
1Glucagon (Glukagon)FDA Link
05/2022
1Pancreatic Polypeptide (Pancreatic Polypeptide (PP))IBA
05/2022
1Insulin (Novolin)FDA Link
05/2022
1C-PeptideIBA
05/2022
1Sodium CitrateFDA LinkGeneric
01/2022
1Streptozocin (Streptozotocin)FDA Link
01/2022
1Gonadal Steroid Hormones (Sex Hormones)IBA
11/2020
1Luteinizing Hormone (Lutropin)FDA LinkGeneric
11/2020
1cyclo(Arg-Pro) (CI 4)IBA
10/2020
1Receptor for Advanced Glycation End ProductsIBA
10/2020
1NADPH Oxidase 4IBA
10/2020
1Blood Glucose (Blood Sugar)IBA
10/2020
1ORALIT (ORS)IBA
10/2020
1NADP (NADPH)IBA
10/2020
1NF-kappa B (NF-kB)IBA
10/2020
1Mitochondrial DNA (mtDNA)IBA
01/2020
1AntioxidantsIBA
01/2020
1Sodium SeleniteIBA
01/2020
1Lipoproteins (Lipoprotein)IBA
01/2020
1Ribosomal Protein S6 Kinases (S6 Kinase)IBA
01/2020
1Nonesterified Fatty Acids (NEFA)IBA
01/2019
1Polysaccharides (Glycans)IBA
11/2018
1AcetylglucosamineIBA
01/2018
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
01/2018
1LigandsIBA
01/2018
1Biomarkers (Surrogate Marker)IBA
01/2018
1Insulin-Like Growth Factor I (IGF-1)IBA
01/2018
1Capsules (Microcapsules)IBA
01/2018
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2017
1CholesterolIBA
01/2017
1HMGB1 Protein (HMG1)IBA
01/2017
1Histones (Histone)IBA
01/2016
1Transcription Factor AP-1 (Transcription Factor AP 1)IBA
11/2015
1Small Interfering RNA (siRNA)IBA
12/2013
1Deubiquitinating EnzymesIBA
12/2013
1CationsIBA
08/2011
1ManganeseIBA
08/2011

Therapy/Procedure

1Intraperitoneal Injections
01/2022
1Therapeutics
01/2018
1Intramuscular Injections
01/2017